|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Bertone-Johnson ER: Vitamin D and breast
cancer. Ann Epidemiol. 19:462–467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bertone-Johnson ER, Chen WY, Holick MF, et
al: Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk
of breast cancer. Cancer Epidemiol Biomarkers Prev. 14:1991–1997.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Krishnan AV, Swami S and Feldman D:
Vitamin D and breast cancer: inhibition of estrogen synthesis and
signaling. J Steroid Biochem Mol Biol. 121:343–348. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Subbaramaiah K, Hudis C, Chang SH, Hla T
and Dannenberg AJ: EP2 and EP4 receptors regulate aromatase
expression in human adipocytes and breast cancer cells. Evidence of
a BRCA1 and p300 exchange. J Biol Chem. 283:3433–3444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Han EH, Kim HG, Hwang YP, Song GY and
Jeong HG: Prostaglandin E2 induces CYP1B1 expression via
ligand-independent activation of the ERα pathway in human breast
cancer cells. Toxicol Sci. 114:204–216. 2010.PubMed/NCBI
|
|
7
|
Han D, Denison MS, Tachibana H and Yamada
K: Effects of estrogenic compounds on immunoglobulin production by
mouse splenocytes. Biol Pharm Bull. 25:1263–1267. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer: links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ristimaki A, Sivula A, Lundin J, et al:
Prognostic significance of elevated cyclooxygenase-2 expression in
breast cancer. Cancer Res. 62:632–635. 2002.PubMed/NCBI
|
|
10
|
Gunnarsson C, Jansson A, Holmlund B, et
al: Expression of COX-2 and steroid converting enzymes in breast
cancer. Oncol Rep. 16:219–224. 2006.PubMed/NCBI
|
|
11
|
Krishnan AV, Shinghal R, Raghavachari N,
Brooks JD, Peehl DM and Feldman D: Analysis of vitamin D-regulated
gene expression in LNCaP human prostate cancer cells using cDNA
microarrays. Prostate. 59:243–251. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Krishnan AV, Swami S, Peng L, Wang J,
Moreno J and Feldman D: Tissue-selective regulation of aromatase
expression by calcitriol: implications for breast cancer therapy.
Endocrinology. 151:32–42. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Moreno J, Krishnan AV, Swami S, Nonn L,
Peehl DM and Feldman D: Regulation of prostaglandin metabolism by
calcitriol attenuates growth stimulation in prostate cancer cells.
Cancer Res. 65:7917–7925. 2005.PubMed/NCBI
|
|
14
|
Greenhough A, Smartt HJ, Moore AE, et al:
The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and
adaptation to the tumour microenvironment. Carcinogenesis.
30:377–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kushner PJ, Agard DA, Greene GL, et al:
Estrogen receptor pathways to AP-1. J Steroid Biochem Mol Biol.
74:311–317. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Feng W, Webb P, Nguyen P, et al:
Potentiation of estrogen receptor activation function 1 (AF-1) by
Src/JNK through a serine 118-independent pathway. Mol Endocrinol.
15:32–45. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen D, Pace PE, Coombes RC and Ali S:
Phosphorylation of human estrogen receptor α by protein kinase A
regulates dimerization. Mol Cell Biol. 19:1002–1015. 1999.
|
|
18
|
Cavalieri E, Chakravarti D, Guttenplan J,
et al: Catechol estrogen quinones as initiators of breast and other
human cancers: implications for biomarkers of susceptibility and
cancer prevention. Biochim Biophys Acta. 1766:63–78.
2006.PubMed/NCBI
|
|
19
|
Bruno RD and Njar VC: Targeting cytochrome
P450 enzymes: a new approach in anti-cancer drug development.
Bioorg Med Chem. 15:5047–5060. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsuchiya Y, Nakajima M, Kyo S, Kanaya T,
Inoue M and Yokoi T: Human CYP1B1 is regulated by estradiol via
estrogen receptor. Cancer Res. 64:3119–3125. 2004. View Article : Google Scholar : PubMed/NCBI
|
